![Ger de Bruin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ger de Bruin
Private Equity Investor chez
Beheer Flevoland Participaties BV
Profil
Mr. Ger de Bruin, MSc, is a Deputy Director at Beheer Flevoland Participaties BV and was previously a Director at Zernike Ventures BV in the Netherlands since 1992, and has experience in patenting and licensing, business development methodology and financing spin-off businesses.
Postes actifs de Ger de Bruin
| Sociétés | Poste | Début |
|---|---|---|
Beheer Flevoland Participaties BV
 Beheer Flevoland Participaties BV Investment ManagersFinance BFP's investment objectives are to create value, stimulate growth and achieve absolute return. They generally take minority stake holdings with a maximum of 49%. They make investments as both lead investor and co-investor. They invest up to EUR 250 thousand in the form of equity and/or convertible subordinated loans and a maximum of EUR 100 thousand in capital. BFP invests in SME firms in a range of stages, from pre-seed to start-up and established businesses primarily based in the province of Flevoland. The Technofonds has a particular focus on four municipalities namely Almere, Lelystad, Dronten and Noordoostpolder. BFP invests across all sectors with the exception of retail trade and Horeca (Hotel/Restaurant/Catering). They have invested in IT, life science and medical technology. BFP looks for firms with innovative techniques, products and processes. Other investment criteria they evaluate include experienced management teams, market potential displaying significant growth possibilities and a sound, realistic business plan. | Private Equity Investor | 04/09/2017 |
Anciens postes connus de Ger de Bruin
| Sociétés | Poste | Fin |
|---|---|---|
Zernike Ventures BV
 Zernike Ventures BV Investment ManagersFinance Zernike Ventures BV is an active manager which invests in innovative technology-based companies located in Netherlands. It participates in later stage and small transactions and focuses on a wide range of sectors and industries. | Directeur en chef des Investissements | 31/12/2013 |
Piculet Biosciences BV
 Piculet Biosciences BV BiotechnologyHealth Technology Develops and markets oligonucleotide binding moieties for pharmaceutical applications | Directeur/Membre du Conseil | - |
Formation de Ger de Bruin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Zernike Ventures BV
Zernike Ventures BV Investment ManagersFinance Zernike Ventures BV is an active manager which invests in innovative technology-based companies located in Netherlands. It participates in later stage and small transactions and focuses on a wide range of sectors and industries. | Finance |
Beheer Flevoland Participaties BV
Beheer Flevoland Participaties BV Investment ManagersFinance BFP's investment objectives are to create value, stimulate growth and achieve absolute return. They generally take minority stake holdings with a maximum of 49%. They make investments as both lead investor and co-investor. They invest up to EUR 250 thousand in the form of equity and/or convertible subordinated loans and a maximum of EUR 100 thousand in capital. BFP invests in SME firms in a range of stages, from pre-seed to start-up and established businesses primarily based in the province of Flevoland. The Technofonds has a particular focus on four municipalities namely Almere, Lelystad, Dronten and Noordoostpolder. BFP invests across all sectors with the exception of retail trade and Horeca (Hotel/Restaurant/Catering). They have invested in IT, life science and medical technology. BFP looks for firms with innovative techniques, products and processes. Other investment criteria they evaluate include experienced management teams, market potential displaying significant growth possibilities and a sound, realistic business plan. | Finance |
Piculet Biosciences BV
Piculet Biosciences BV BiotechnologyHealth Technology Develops and markets oligonucleotide binding moieties for pharmaceutical applications | Health Technology |
Wageningen University
 Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
